Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04240756 · ClinicalTrials.gov registry record · Phase 3
Treating Parents with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial
A Phase 3 study of ADHD and Parenting, sponsored by University of Maryland, College Park.
- Active
- Registry status
- Phase 3
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT04240756 is a Phase 3 study of ADHD and Parenting that is active but no longer recruiting, run by University of Maryland, College Park. The registered enrollment target is 240 participants, above the 187-participant average among 75 other ADHD trials with a reported enrollment target (28% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04240756, a Phase 3 study of ADHD and Parenting, is active but no longer recruiting, sponsored by University of Maryland, College Park.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the effectiveness of combined parental stimulant medication and behavioral parent training (BPT) versus BPT alone on child ADHD-related impairment (primary outcome), child ADHD and externalizing symptoms, time to child stimulant prescription (secondary child outcomes) and parental ADHD impairment, parental ADHD symptoms, parenting, and BPT engagement (parental outcomes/target mechanisms). This study will also assess the care delivery context and develop an implementation approach for treatment of families with a parent with ADHD and a child with elevated ADHD symptoms via telehealth in primary care sites providing pediatric care.
Interventions
- BEHAVIORAL Behavioral Parent Training
- DRUG Extended release mixed amphetamine salts (MAS)
Study Locations (1)
Maryland
- University of Maryland - College Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2020-08-06 |
| Est. Completion | 2025-07-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04240756
The ClinicalTrials.gov registry entry for NCT04240756 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 187-participant average among 75 other ADHD trials with a reported enrollment target (28% higher). The listed sponsor is University of Maryland, College Park, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with ADHD appearing as the primary indexed condition, and to 2 interventions - of which Behavioral Parent Training is the first listed.
NCT04240756 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04240756 about?
NCT04240756 is a clinical study titled "Treating Parents with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial". This study will compare the effectiveness of combined parental stimulant medication and behavioral parent training (BPT) versus BPT alone on child ADHD-related impairment (primary outcome), child ADHD and externalizing symptoms, time to child stimulant prescription (secondary child outcomes) and par...
What is the current status of trial NCT04240756?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 240 participants. The study started on 2020-08-06. Estimated completion is 2025-07-31.
What conditions does trial NCT04240756 study?
This clinical trial studies the following conditions: ADHD, Parenting.
What interventions are being tested in trial NCT04240756?
The interventions under investigation include: Behavioral Parent Training (BEHAVIORAL), Extended release mixed amphetamine salts (MAS) (DRUG).
Who is sponsoring clinical trial NCT04240756?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04240756 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
RECRUITING · Phase 3
-
Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
COMPLETED · Phase 3
-
Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD
COMPLETED · Phase 3
-
Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD
COMPLETED · Phase 3
-
PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
COMPLETED · Phase 3
-
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.